Cargando…
Prescribing of evidence-based diabetes pharmacotherapy in patients with metabolic dysfunction-associated steatohepatitis
INTRODUCTION: Metabolic dysfunction-associated steatohepatitis (MASH) is highly prevalent in type 2 diabetes (T2D). Pioglitazone and glucagon-like peptide-1 receptor agonists (GLP-1RA) are medications used in T2D that can resolve MASH and should be considered in all patients with T2D and MASH. We as...
Autores principales: | Alexopoulos, Anastasia-Stefania, Parish, Alice, Olsen, Maren, Batch, Bryan C, Moylan, Cynthia, Crowley, Matthew J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10689360/ https://www.ncbi.nlm.nih.gov/pubmed/38030391 http://dx.doi.org/10.1136/bmjdrc-2023-003763 |
Ejemplares similares
-
Potential Impact of Prescribing Metformin According to eGFR Rather Than Serum Creatinine
por: Tuot, Delphine S., et al.
Publicado: (2015) -
Using multi-criteria decision analysis to describe stakeholder preferences for new quality improvement initiatives that could optimise prescribing in England
por: Khanal, Saval, et al.
Publicado: (2023) -
Factors associated with adherence to glaucoma pharmacotherapy in the primary care setting
por: Cohen Castel, Orit, et al.
Publicado: (2014) -
Social prescribing: less rhetoric and more reality. A systematic review of the evidence
por: Bickerdike, Liz, et al.
Publicado: (2017) -
Evaluation of rational prescribing in a hospital paediatric outpatient clinic in Nigeria
por: Okoye, Blessing Ijeoma, et al.
Publicado: (2022)